San Diego-based gene-sequencing giant Illumina got tangled in the United States’ trade tensions Tuesday as China placed the ...

We recently published a list of Jim Cramer Discusses These 10 Stocks & Dissects President Trump’s China Tariffs. In this ...

Illumina, Inc. engages in the development ... and enables the adoption of a variety of genomic solutions. The firm's products include instruments, kits and reagents, selection tools, and software ...

Analysts said the move comes amid rising trade tensions with the U.S. and as Illumina faces stiff competition in China’s ...

Shares of Illumina (NASDAQ: ILMN) were falling on Friday. The company's stock was down by as much as 11.4% early in the session, and was still off by 8.7% as of 2:38 p.m. ET. At that time ...

Leading American genomic sequencing firm Illumina says it is evaluating Beijing’s announcement with hope of ‘positive ...

Illumina is down 15.2% since the beginning of the year, and at $111.06 per share, it is trading 28.4% below its 52-week high of $155.15 from November 2024. Investors who bought $1,000 worth of ...

China announced a wide range of measures on Tuesday targeting U.S. businesses including Google , farm equipment makers and ...

"We've leveraged our team's know-how with Illumina's products to get to that excellent clinical implementation." The Precision Medicine Institute has integrated a suite of Illumina products to ...

“Despite Illumina manufacturing products in Singapore and Taiwan, the Unreliable Entity List might restrict sales,” Souda wrote. “The Unreliable Entity List has been cited as more akin to ...

Illumina has struggled to boost sales and consistently deliver positive earnings. Its Q4 report was largely a disappointment, and management's 2025 guidance came in below Wall Street's ...